| 1 |
Jeffrey A. Klang |
Arco Chemical Technology |
4 |
| 2 |
Haimanti Dorai |
Creative Biomolecules |
3 |
| 3 |
Gregory F. Helma |
Arco Chemical Technology |
2 |
| 3 |
Stephen B. Ruddy |
Elan Pharma International |
2 |
| 3 |
Sreenivasan Padmanabhan |
Johnson Matthey Public Limited |
2 |
| #6 |
Dimitris Agrafiotis |
3-Dimensional Pharmaceuticals |
1 |
| #6 |
Francis C. Maslanka |
Cephalon |
1 |
| #6 |
Todd Rimmer |
Intel |
1 |
| #6 |
Michael Klimas |
Astrazeneca Ab |
1 |
| #6 |
Simon Whitnell |
Dopaco |
1 |
| #6 |
Frederick C. Kruesi |
Unisys |
1 |
| #6 |
Lu Tianbao |
3-Dimensional Pharmaceuticals |
1 |
| #6 |
David A. Pienkowski |
University Of Kentucky |
1 |
| #6 |
George E. Niznik |
Kawasaki Chemical Holding Co. |
1 |
| #6 |
Carl J. Sullivan |
Arco Chemical Technology |
1 |
| #6 |
Charles Papciak |
West |
1 |
| #6 |
James Mullen |
Phoenix Intangibles Holding |
1 |
| #6 |
Nalin Subasinghe |
3-Dimensional Pharmaceuticals |
1 |